Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC - Quiz - MDSpire

Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC

  • By

  • Bernd Uhl

  • Dennis Eggert

  • Bojan Smiljanov

  • Katharina von Thun und Hohenstein

  • Christoph Walz

  • Gisela Kranz

  • Sabina Schwenk-Zieger

  • Florian Haring

  • Joshua Luft

  • Jiahang Song

  • Vincent Holtmann

  • Philipp Baumeister

  • Christoph A. Reichel

  • Olivier Gires

  • Martin Canis

  • Christian Betz

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC

  • by Bernd Uhl, Dennis Eggert, Bojan Smiljanov, Katharina von Thun und Hohenstein, Christoph Walz, Gisela Kranz, Sabina Schwenk-Zieger, Florian Haring, Joshua Luft, Jiahang Song, Vincent Holtmann, Philipp Baumeister, Christoph A. Reichel, Olivier Gires, Martin Canis, Christian Betz

  • May 25, 2026

Related Content

Tongue cancer microbial biomarkers: landscape of saliva, cancer tissue, and para-carcinoma tissue

Overall survival and prognostic factors of oral cavity and oropharyngeal squamous cell carcinomas in Saudi Arabia: a population-based cohort study (2000–2019)

Real-world healthcare resource use and costs associated with the management of locally advanced head and neck cancer in Portugal – TRACE2 study